UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001028 |
|---|---|
| Receipt number | R000001240 |
| Scientific Title | Randomized Phase III Trial of Irinotecan plus Cisplatin vs. bi-weekly Irinotecan after S-1 failure for Patients with Advanced and Recurrent Gastric Cancer |
| Date of disclosure of the study information | 2008/04/01 |
| Last modified on | 2014/02/13 09:14:49 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/02/13 14:02:59 | ||
| 2 | Update | 2008/04/22 13:30:52 | Recruitment status |
|
| 3 | Update | 2009/02/13 09:51:26 | Last follow-up date |
|
| 4 | Update | 2009/08/25 16:48:12 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 5 | Update | 2009/11/17 10:53:49 | Recruitment status |
|
| 6 | Update | 2009/12/21 13:24:49 | Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 7 | Update | 2009/12/21 13:25:25 | Last follow-up date |
|
| 8 | Update | 2010/08/17 09:06:47 | Address |
|
| 9 | Update | 2010/08/26 15:24:17 | Acronym Acronym |
|
| 10 | Update | 2011/02/15 10:25:28 | Last follow-up date |
|
| 11 | Update | 2011/08/17 10:00:11 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 12 | Update | 2011/08/17 10:00:26 | Recruitment status |
|
| 13 | Update | 2011/11/10 11:55:14 | Address Address Address1 |
|
| 14 | Update | 2012/03/13 09:54:47 | Email |
|
| 15 | Update | 2014/02/13 09:14:49 | Recruitment status |
